Trial · NCT01458587
Outcomes39
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 39
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Lesion Clearance Rate | Week 12 | ITT analysis with LOCF | percentage of lesions cleared | MEDIAN |
| SECONDARY | Lesion Clearance Rate | Week 8 | ITT LOCF | percentage of lesions cleared | MEDIAN |
| SECONDARY | Complete Clearance Rate | Week 8 | ITT LOCF | arms 100% cleared | NUMBER |
| SECONDARY | Complete Clearance Rate | Week 12 | ITT LOCF | arms 100% cleared | NUMBER |
| SECONDARY | Partial Clearance Rate | Baseline and Week 8 | ITT LOCF | arms >75% cleared | NUMBER |
| SECONDARY | Partial Clearance Rate | Baseline and Week 12 | ITT LOCF | arms >75% cleared | NUMBER |
| SECONDARY | Subject Satisfaction Score | Week 12 | ITT | participants | NUMBER |
| SECONDARY | Hyperpigmentation at Baseline | Baseline | ITT | participants | NUMBER |
| SECONDARY | Hyperpigmentation at Visit 3 | 2 weeks after PDT #1 | ITT | participants | NUMBER |
| SECONDARY | Hyperpigmentation at Visit 4 | 8 weeks after PDT #1 | ITT | participants | NUMBER |
| SECONDARY | Hyperpigmentation at Visit 5 | 12 weeks after PDT #1 | ITT | participants | NUMBER |
| SECONDARY | Hypopigmentation at Baseline | Baseline | ITT | participants | NUMBER |
| SECONDARY | Hypopigmentation at Visit 3 | 2 Weeks after PDT #1 | ITT | participants | NUMBER |
| SECONDARY | Hypopigmentation at Visit 4 | 8 Weeks after PDT #1 | ITT | participants | NUMBER |
| SECONDARY | Hypopigmentation at Visit 5 | 12 Weeks after PDT #1 | ITT | participants | NUMBER |
| SECONDARY | Erythema at Baseline | Baseline | ITT | participants | NUMBER |
| SECONDARY | Erythema Post-Light Treatment | 5 Minutes after PDT #1 | ITT | participants | NUMBER |
| SECONDARY | Erythema at Visit 3 | 2 Weeks after PDT #1 | ITT | participants | NUMBER |
| SECONDARY | Erythema at Visit 4 | 8 Weeks after PDT #1 | ITT | participants | NUMBER |
| SECONDARY | Erythema at Visit 5 | 12 Weeks after PDT #1 | ITT | participants | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01458587/outcomes